Pliant Therapeutics, Inc. (NASDAQ:PLRX – Get Free Report) was up 6.9% during mid-day trading on Monday . The stock traded as high as $18.32 and last traded at $18.32. Approximately 121,803 shares traded hands during mid-day trading, a decline of 71% from the average daily volume of 420,464 shares. The stock had previously closed at […]
Pliant Therapeutics, Inc Expected to Earn Q1 2024 Earnings of ($0 73) Per Share (NASDAQ:PLRX) modernreaders.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from modernreaders.com Daily Mail and Mail on Sunday newspapers.
Pliant Therapeutics, Inc. (NASDAQ:PLRX – Get Rating)’s share price dropped 4.2% during trading on Friday . The stock traded as low as $22.32 and last traded at $22.40. Approximately 78,499 shares traded hands during trading, a decline of 90% from the average daily volume of 796,915 shares. The stock had previously closed at $23.39. Wall […]
Eversept Partners LP lessened its stake in Pliant Therapeutics, Inc. (NASDAQ:PLRX – Get Rating) by 53.3% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 137,423 shares of the company’s stock after selling 156,680 shares during the period. Eversept Partners LP […]
Pliant Therapeutics (NASDAQ:PLRX – Get Rating) had its price objective raised by Oppenheimer from $44.00 to $51.00 in a research note released on Wednesday morning, The Fly reports. Other research analysts also recently issued research reports about the stock. Needham & Company LLC reaffirmed a buy rating and issued a $45.00 price target on shares […]